LEONID VOROBYEV: Open Payments
NPI 1245259431 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,433 in 31 payments from 8 companies in 2025. Trend: 2023 $327 · 2024 $561 · 2025 $1,433
Food & beverage: $1,407Education: $25
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 7 | $502 |
| Axsome Therapeutics, Inc. | 7 | $365 |
| Alkermes, Inc. | 3 | $282 |
| Vanda Pharmaceuticals Inc. | 10 | $184 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Janssen Pharmaceuticals, Inc | 1 | $24 |
| Bausch Health US, LLC | 1 | $19 |
Products named: REXULTI, Auvelity, LYBALVI, FANAPT, TRINTELLIX, CAPLYTA, SPRAVATO, APLENZIN.
Industry payments across NY — which companies pay providers there.
